Drug Patents owned by Acelrx Pharms

1. Drug name - DSUVIA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8778393 ACELRX PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Jan, 2027

(4 years from now)

US9320710 ACELRX PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Jan, 2027

(4 years from now)

US10342762 ACELRX PHARMS Small-volume oral transmucosal dosage forms Jan, 2027

(4 years from now)

US8231900 ACELRX PHARMS Small-volume oral transmucosal dosage Jan, 2027

(4 years from now)

US8252328 ACELRX PHARMS Bioadhesive drug formulations for oral transmucosal delivery Jan, 2027

(4 years from now)

US9744129 ACELRX PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Jan, 2027

(4 years from now)

US8252329 ACELRX PHARMS Bioadhesive drug formulations for oral transmucosal delivery Jan, 2027

(4 years from now)

US8226978 ACELRX PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Jan, 2027

(4 years from now)

US8865211 ACELRX PHARMS Bioadhesive drug formulations for oral transmucosal delivery Jan, 2027

(4 years from now)

US10245228 ACELRX PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Jan, 2027

(4 years from now)

US10507180 ACELRX PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Jan, 2027

(4 years from now)

US8535714 ACELRX PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Jan, 2027

(4 years from now)

US8778394 ACELRX PHARMS Small-volume oral transmucosal dosage forms Jan, 2027

(4 years from now)

US8574189 ACELRX PHARMS Storage and dispensing devices for administration of oral transmucosal dosage forms Mar, 2030

(7 years from now)

US10896751 ACELRX PHARMS Storage and dispensing devices for administration of oral transmucosal dosage forms Mar, 2030

(7 years from now)

US8202535 ACELRX PHARMS Small-volume oral transmucosal dosage forms Oct, 2030

(8 years from now)

US8865743 ACELRX PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Oct, 2030

(8 years from now)

US8945592 ACELRX PHARMS Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same Jul, 2031

(8 years from now)

Drugs and Companies using SUFENTANIL CITRATE ingredient

Treatment: Treatment of acute pain

Dosage: TABLET;SUBLINGUAL

More Information on Dosage
Strength Dosage Availability
EQ 0.03MG BASE TABLET;SUBLINGUAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.